Literature DB >> 23918157

Molecular etiology of hearing impairment associated with nonsyndromic enlarged vestibular aqueduct in East China.

Yongchuan Chai1, Zhiwu Huang, Zheng Tao, Xiaohua Li, Lei Li, Yun Li, Hao Wu, Tao Yang.   

Abstract

Recessive mutations in SLC26A4 and in rarer cases double heterozygous mutations of FOXI1/SLC26A4 and KCNJ10/SLC26A4 lead to hearing impairment associated with enlarged vestibular aqueduct (EVA), the most common inner ear malformation. In our large cohort study, we addressed several important questions to the molecular etiology of this disorder. The overall prevalence of SLC26A4 mutations in nonsyndromic childhood sensorineural hearing loss (11.2%, 37/330) were determined by sequencing of SLC26A4 in 330 hearing impaired children who did not undergo inner ear radiologic imaging prior to their genetic test. The penetrance of EVA in bi-allelic SLC26A4 mutation carriers (100%, 37/37) was determined by follow-up computed tomography scanning. Combined with the study of 140 additional probands diagnosed with nonsyndromic EVA, we characterized the mutation spectrum of SLC26A4 in East China, which consisted of 19 novel SLC26A4 mutations and differed from those reported in other regions of China.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  SLC26A4; enlargement of vestibular aqueduct; hearing impairment; mutation

Mesh:

Substances:

Year:  2013        PMID: 23918157     DOI: 10.1002/ajmg.a.36068

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  The extracellular loop of pendrin and prestin modulates their voltage-sensing property.

Authors:  Makoto F Kuwabara; Koichiro Wasano; Satoe Takahashi; Justin Bodner; Tomotaka Komori; Sotaro Uemura; Jing Zheng; Tomohiro Shima; Kazuaki Homma
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

2.  The R130S mutation significantly affects the function of prestin, the outer hair cell motor protein.

Authors:  Satoe Takahashi; Mary Ann Cheatham; Jing Zheng; Kazuaki Homma
Journal:  J Mol Med (Berl)       Date:  2016-04-04       Impact factor: 4.599

3.  Mutation analysis of the SLC26A4, FOXI1 and KCNJ10 genes in individuals with congenital hearing loss.

Authors:  Lynn M Pique; Marie-Luise Brennan; Colin J Davidson; Frederick Schaefer; John Greinwald; Iris Schrijver
Journal:  PeerJ       Date:  2014-05-08       Impact factor: 2.984

4.  Further characterisation of the recently described SLC26A4 c.918+2T>C mutation and reporting of a novel variant predicted to be damaging.

Authors:  A C Gonçalves; R Santos; A O'Neill; P Escada; G Fialho; H Caria
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

Review 5.  Diagnostic Value of SLC26A4 Mutation Status in Hereditary Hearing Loss With EVA: A PRISMA-Compliant Meta-Analysis.

Authors:  Ya-Jie Lu; Jun Yao; Qin-Jun Wei; Guang-Qian Xing; Xin Cao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

6.  A Novel Frameshift Mutation of SLC26A4 in a Korean Family With Nonsyndromic Hearing Loss and Enlarged Vestibular Aqueduct.

Authors:  Borum Sagong; Jeong-In Baek; Kyu-Yup Lee; Un-Kyung Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-07       Impact factor: 3.372

7.  Different Rates of the SLC26A4-Related Hearing Loss in Two Indigenous Peoples of Southern Siberia (Russia).

Authors:  Valeriia Yu Danilchenko; Marina V Zytsar; Ekaterina A Maslova; Marita S Bady-Khoo; Nikolay A Barashkov; Igor V Morozov; Alexander A Bondar; Olga L Posukh
Journal:  Diagnostics (Basel)       Date:  2021-12-17

8.  Increased diagnosis of enlarged vestibular aqueduct by multiplex PCR enrichment and next-generation sequencing of the SLC26A4 gene.

Authors:  Yongan Tian; Hongen Xu; Danhua Liu; Juanli Zhang; Zengguang Yang; Sen Zhang; Huanfei Liu; Ruijun Li; Yingtao Tian; Beiping Zeng; Tong Li; Qianyu Lin; Haili Wang; Xiaohua Li; Wei Lu; Ying Shi; Yan Zhang; Hui Zhang; Chang Jiang; Ying Xu; Bei Chen; Jun Liu; Wenxue Tang
Journal:  Mol Genet Genomic Med       Date:  2021-06-25       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.